Photo by galen_crout from unsplash
Studies comparing dipeptidyl peptidase‐4 inhibitors (DPP4Is) to sulfonylureas (SUs) are unavailable for frail older adults, especially nursing home (NH) residents. We examined the effects of DPP4Is versus SUs on severe… Click to show full abstract
Studies comparing dipeptidyl peptidase‐4 inhibitors (DPP4Is) to sulfonylureas (SUs) are unavailable for frail older adults, especially nursing home (NH) residents. We examined the effects of DPP4Is versus SUs on severe adverse glycemic events, cardiovascular events, and death among NH residents.
Keywords:
peptidase inhibitors;
frail older;
dipeptidyl peptidase;
older adults;
comparative safety
Journal Title: Journal of the American Geriatrics Society
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American Geriatrics Society
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!